After puberty, sex-related differences emerge in the memory B-cell compartment, with cisgender women (assigned female at birth) showing higher frequencies than age-matched cisgender men. As these cells are essential for long-term humoral immunity and rapid antibody responses upon antigen re-exposure, this difference may have functional relevance. The attenuation of this difference after menopause points to an important hormonal contribution. This interpretation is further supported by observations in transgender individuals: suppression of endogenous oestrogens in transgender men with an XX chromosomal complement was accompanied by a reduction in memory B-cell frequencies, whereas oestrogen administration to transgender women with an XY karyotype did not induce a comparable increase. A similar pattern has been reported in postmenopausal women, in whom hormone replacement therapy (HRT) was associated with higher memory B-cell counts than in untreated counterparts [21]. Reprinted from [22] under a Creative Commons CC-BY license.
Emanuele Montomoli is the founder and Chief Scientific Officer of VisMederi srl. Calogero Caruso, who is the Editor-in-Chief of Exploration of Immunology, had no involvement in the decision-making or the review process of this manuscript. The other authors declare no conflicts of interest.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Caruso C, Marcon G, Accardi G, Aiello A, Calabrò A, Ligotti ME, et al. Role of Sex and Age in Fatal Outcomes of COVID-19: Women and Older Centenarians Are More Resilient.Int J Mol Sci. 2023;24:2638. [DOI] [PubMed] [PMC]
Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19.Nat Rev Microbiol. 20201;19:141–54. [DOI] [PubMed] [PMC]
Tadiri CP, Gisinger T, Kautzy-Willer A, Kublickiene K, Herrero MT, Raparelli V, et al.; GOING-FWD Consortium. The influence of sex and gender domains on COVID-19 cases and mortality.Can Med Assoc J. 2020;192:E1041–5. [DOI] [PubMed] [PMC]
Agrawal S, Salazar J, Tran TM, Agrawal A. Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2.Front Immunol. 2021;12:739757. [DOI] [PubMed] [PMC]
Calabrò A, Pawelec G, Caruso C, Trombetta CM. Immune aging of men and women: Different susceptibility to infectious diseases and different response to vaccines. In: Caruso C, editor. Role of Sex and Gender in Aging and Longevity. Academic Press; 202. pp. 183–203.
Calabrò A, Accardi G, Aiello A, Caruso C, Candore G. Sex and gender affect immune aging.Front Aging. 2023;4:1272118. [DOI] [PubMed] [PMC]
Arakelyan NA, Kupriyanova DA, Vasilevska J, Rogaev EI. Sexual dimorphism in immunity and longevity among the oldest old.Front Immunol. 2025;16:1525948. [DOI] [PubMed] [PMC]
Calabrò A, Aiello A, Montomoli E, Pawelec G, Trombetta CM, Caruso C. The influence of sex and gender differences in shaping the immune response to influenza infection and vaccination.Explor Immunol. 2026;6:1003244. [DOI]
Aliberti SM, Capunzo M, Galimberti D, Accardi G, Aiello A, Calabrò A, et al. Ageing Trajectories: Exposome-Driven Pathobiological Mechanisms and Implications for Prevention from Blue Zones and Italian Longevity Hotspots Such as Cilento and Sicilian Mountain Villages.Int J Mol Sci. 2025;26:4796. [DOI] [PubMed] [PMC]
Bucher ML, Anderson FL, Lai Y, Dicent J, Miller GW, Zota AR. Exposomics as a tool to investigate differences in health and disease by sex and gender.Exposome. 2023;3:osad003. [DOI] [PubMed] [PMC]
COVID-19 Host Genetics Initiative. A second update on mapping the human genetic architecture of COVID-19.Nature. 2023;621:E7–26. [DOI] [PubMed] [PMC]
Candore G, Accardi G, Aiello A, Baggio G, Bellini T, Calabrese V, et al. Sex and Gender in Ageing and Longevity: Highlights from an International Course.Transl Med UniSa. 2024;26:15–29. [DOI] [PubMed] [PMC]
Sciarra F, Campolo F, Franceschini E, Carlomagno F, Venneri MA. Gender-Specific Impact of Sex Hormones on the Immune System.Int J Mol Sci. 2023;24:6302. [DOI] [PubMed] [PMC]
Harding AT, Heaton NS. The Impact of Estrogens and Their Receptors on Immunity and Inflammation during Infection.Cancers (Basel). 2022;14:909. [DOI] [PubMed] [PMC]
Huang M, Xu H. Genetic susceptibility to autoimmunity—Current status and challenges.Adv Immunol. 2022;156:25–54. [DOI] [PubMed]
Mohammad I, Starskaia I, Nagy T, Guo J, Yatkin E, Väänänen K, et al. Estrogen receptor α contributes to T cell–mediated autoimmune inflammation by promoting T cell activation and proliferation.Sci Signal. 2018;11:e11. [DOI] [PubMed]
Feng Z, Liao M, Zhang L. Sex differences in disease: sex chromosome and immunity.J Transl Med. 2024;22:1150. [DOI] [PubMed] [PMC]
Sun Z, Fan J, Wang Y. X-Chromosome Inactivation and Related Diseases.Genet Res (Camb). 2022;2022:1391807. [DOI] [PubMed] [PMC]
Nie J, Li YY, Zheng SG, Tsun A, Li B. FOXP3+ Treg Cells and Gender Bias in Autoimmune Diseases.Front Immunol. 2015;6:493. [DOI] [PubMed] [PMC]
Peckham H, Radziszewska A, Sikora J, de Gruijter NM, Restuadi R, Kartawinata M, et al. Estrogen influences class-switched memory B cell frequency only in humans with two X chromosomes.J Exp Med. 2025;222:e20241253. [DOI] [PubMed] [PMC]
Calabrò A, Accardi G, Aiello A, Zarcone R, Candore G. Autoimmune diseases are more common in women: insights into sex and gender differences in autoimmunity.Explor Immunol. 2026;6:1003241. [DOI]
Gutiérrez-Hurtado IA, Sánchez-Méndez AD, Becerra-Loaiza DS, Rangel-Villalobos H, Torres-Carrillo N, Gallegos-Arreola MP, et al. Loss of the Y Chromosome: A Review of Molecular Mechanisms, Age Inference, and Implications for Men’s Health.Int J Mol Sci. 2024;25:4230. [DOI] [PubMed] [PMC]
Pérez-Jurado LA, Cáceres A, Balagué-Dobón L, Esko T, López de Heredia M, Quintela I, et al.; SCOURGE Cohort Group; González JR. Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2.Commun Biol. 2024;7:202. [DOI] [PubMed] [PMC]
Berghöfer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H. TLR7 Ligands Induce Higher IFN-α Production in Females.J Immunol. 2006;177:2088–96. [DOI] [PubMed]
Baratchian M, McManus JM, Berk MP, Nakamura F, Mukhopadhyay S, Xu W, et al. Androgen regulation of pulmonary AR, TMPRSS2 and ACE2 with implications for sex-discordant COVID-19 outcomes.Sci Rep. 2021;11:11130. [DOI] [PubMed] [PMC]
Horowitz JE, Kosmicki JA, Damask A, Sharma D, Roberts GHL, Justice AE, et al. Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease.Nat Genet. 2022;54:382–92. [DOI] [PubMed] [PMC]
Van den Eynde J, McCutcheon KRG. Angiotensin-converting enzyme 2, sex differences, and COVID-19: The missing link.Int J Cardiol. 2021;322:293. [DOI] [PubMed] [PMC]
Plebani M, Lippi G. Sex and gender differences in COVID-19: a narrative review.Ital J Gender-Specific Med. 2022;8:105–11.
Ligotti ME, Pojero F, Accardi G, Aiello A, Caruso C, Duro G, et al. Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?Front Cell Dev Biol. 2021;9:725606. [DOI] [PubMed] [PMC]
Buttenschön J, Mattner J. The interplay between dendritic cells and CD8 T lymphocytes is a crucial component of SARS-CoV-2 immunity.Cell Mol Immunol. 2021;18:247–9. [DOI] [PubMed] [PMC]
Aiello A, Farzaneh F, Candore G, Caruso C, Davinelli S, Gambino CM, et al. Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention.Front Immunol. 2019;10:2247. [DOI] [PubMed] [PMC]
Franck M, Tanner KT, Tennyson RL, Daunizeau C, Ferrucci L, Bandinelli S, et al. Nonuniversality of inflammaging across human populations.Nat Aging. 2025;5:1471–80. [DOI] [PubMed]
Hu B, Huang S, Yin L. The cytokine storm and COVID‐19.J Med Virol. 2020;93:250–6. [DOI] [PubMed] [PMC]
Gomez Rial J, Redondo E, Rivero-Calle I, Mascarós E, Ocaña D, Jimeno I, et al. Immunofitness in the elderly: The role of vaccination in promoting healthy aging.Hum Vaccines Immunother. 2026;22:2624234. [DOI] [PubMed] [PMC]
Ligotti ME, Aiello A, Accardi G, Aprile S, Bonura F, Bulati M, et al. Analysis of T and NK cell subsets in the Sicilian population from young to supercentenarian: The role of age and gender.Clin Exp Immunol. 2021;205:198–212. [DOI] [PubMed] [PMC]
Márquez EJ, Chung CH, Marches R, Rossi RJ, Nehar-Belaid D, Eroglu A, et al. Sexual-dimorphism in human immune system aging.Nat Commun. 2020;11:751. [DOI] [PubMed] [PMC]
Nielsen J, Nørgaard SK, Lanzieri G, Vestergaard LS, Moelbak K. Sex-differences in COVID-19 associated excess mortality is not exceptional for the COVID-19 pandemic.Sci Rep. 2021;11:20815. [DOI] [PubMed] [PMC]
Jacobsen H, Klein SL. Sex Differences in Immunity to Viral Infections.Front Immunol. 2021;12:720952. [DOI] [PubMed] [PMC]
Zarulli V, Barthold Jones JA, Oksuzyan A, Lindahl-Jacobsen R, Christensen K, Vaupel JW. Women live longer than men even during severe famines and epidemics.Proc Natl Acad Sci U S A. 2018;115:E832–40. [DOI] [PubMed] [PMC]
Poulain M, Chambre D, Pes GM. Centenarians exposed to the Spanish flu in their early life better survived to COVID-19.Aging (Albany NY). 2021;13:21855–65. [DOI] [PubMed] [PMC]
Caruso C, Accardi G, Aiello A, Calabrò A, Ligotti ME, Candore G. Centenarians born before 1919 are resistant to COVID-19.Aging Clin Exp Res. 2023;35:217–20. [DOI] [PubMed] [PMC]
Trombetta CM, Accardi G, Aiello A, Calabrò A, Caruso C, Ligotti ME, et al. Centenarians, semi and supercentenarians, COVID-19 and Spanish flu: a serological assessment to gain insight into the resilience of older centenarians to COVID-19.Immun Ageing. 2024;21:44. [DOI] [PubMed] [PMC]
de Castro MV, Silva MVR, Naslavsky MS, Scliar MO, Nunes K, Passos-Bueno MR, et al. The oldest unvaccinated Covid-19 survivors in South America.Immun Ageing. 2022;19:57. [DOI] [PubMed] [PMC]
Accardi G, Calabrò A, Caldarella R, Caruso C, Ciaccio M, Di Simone M, et al. Immune-Inflammatory Response in Lifespan—What Role Does It Play in Extreme Longevity? A Sicilian Semi- and Supercentenarians Study.Biology (Basel). 2024;13:1010. [DOI] [PubMed] [PMC]
Santos-Pujol E, Noguera-Castells A, Casado-Pelaez M, García-Prieto CA, Vasallo C, Campillo-Marcos I, et al. The multiomics blueprint of the individual with the most extreme lifespan.Cell Rep Med. 2025;6:102368. [DOI] [PubMed] [PMC]
Bertolazzi G, Calabrò A, Accardi G, Aiello A, Caruso C, Corsale AM, et al. B Cell Levels in Centenarians, Semi-Supercentenarians, and Supercentenarians: Descriptive Analysis by Age, Sex, Cytomegalovirus Status, and Interleukin-6.J Ageing Longev. 2026;6:9. [DOI]
Ligotti ME, Accardi G, Aiello A, Aprile S, Calabrò A, Caldarella R, et al. Sicilian semi- and supercentenarians: identification of age-related T-cell immunophenotype to define longevity trait.Clin Exp Immunol. 2023;214:61–78. [DOI] [PubMed] [PMC]
Ligotti ME, Accardi G, Aiello A, Calabrò A, Caruso C, Corsale AM, et al. Sicilian semi- and supercentenarians: age-related Tγδ cell immunophenotype contributes to longevity trait definition.Clin Exp Immunol. 2024;216:1–12. [DOI] [PubMed] [PMC]
Ligotti ME, Accardi G, Aiello A, Calabrò A, Caruso C, Corsale AM, et al. Sicilian semi- and supercentenarians: age-related NK cell immunophenotype and longevity trait definition.Transl Med UniSa. 2023;25:11–5. [DOI] [PubMed] [PMC]
Hashimoto K, Kouno T, Ikawa T, Hayatsu N, Miyajima Y, Yabukami H, et al. Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians.Proc Natl Acad Sci U S A. 2019;116:24242–51. [DOI] [PubMed] [PMC]
Barbi E, Lagona F, Marsili M, Vaupel JW, Wachter KW. The plateau of human mortality: Demography of longevity pioneers.Science. 2018;360:1459–61. [DOI] [PubMed] [PMC]
Baker C, Kim M, Benayoun BA. A researcher’s guide to studying sex differences in immune aging.Trends Mol Med. 2025;31:702–17. [DOI] [PubMed] [PMC]
Patin E, Hasan M, Bergstedt J, Rouilly V, Libri V, Urrutia A, et al. Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors.Nat Immunol. 2018;19:302–14. [DOI] [PubMed]
Houweling L, Maitland-Van der Zee AH, Holtjer JCS, Bazdar S, Vermeulen RCH, Downward GS, et al. The effect of the urban exposome on COVID-19 health outcomes: A systematic review and meta-analysis.Environ Res. 2024;240:117351. [DOI] [PubMed]
Baumer Y, Farmer N, Premeaux TA, Wallen GR, Powell-Wiley TM. Health Disparities in COVID-19: Addressing the Role of Social Determinants of Health in Immune System Dysfunction to Turn the Tide.Front Public Health. 2020;8:559312. [DOI] [PubMed] [PMC]
Bartolomeo N, Giotta M, Tafuri S, Trerotoli P. Impact of Socioeconomic Deprivation on the Local Spread of COVID-19 Cases Mediated by the Effect of Seasons and Restrictive Public Health Measures: A Retrospective Observational Study in Apulia Region, Italy.Int J Environ Res Public Health. 2022;19:11410. [DOI] [PubMed] [PMC]
Beegle K, Demombynes G, de Walque D, Gubbins P, Veillard J. COVID-19 increased existing gender mortality gaps in high-income more than middle-income countries.Int J Infect Dis. 2024;148:107167. [DOI] [PubMed]
Ameye H, Swinnen J. Obesity, income and gender: The changing global relationship.Glob Food Secur. 2019;23:267–81. [DOI]
Mariani G, Kasznia-Brown J, Paez D, Mikhail MN, H Salama D, Bhatla N, et al. Improving women's health in low-income and middle-income countries. Part I: challenges and priorities.Nucl Med Commun. 2017;38:1019–23. [DOI] [PubMed] [PMC]
Bambra C, Albani V, Franklin P. COVID-19 and the gender health paradox.Scand J Public Health. 2021;49:17–26. [DOI] [PubMed] [PMC]
de Frel DL, Atsma DE, Pijl H, Seidell JC, Leenen PJM, Dik WA, et al. The Impact of Obesity and Lifestyle on the Immune System and Susceptibility to Infections Such as COVID-19.Front Nutr. 2020;7:597600. [DOI] [PubMed] [PMC]
Cui Y, Zhu Q, Lou C, Gao E, Cheng Y, Zabin LS, et al. Gender differences in cigarette smoking and alcohol drinking among adolescents and young adults in Hanoi, Shanghai, and Taipei.J Int Med Res. 2018;46:5257–68. [DOI] [PubMed] [PMC]
Tarriño M, Gutiérrez-Bautista JF, Durán MJO, Garcia-Diaz A, Cabrera-Serrano AJ, Sainz J, et al. The role of intestinal microbiota in the humoral response to SARS-CoV-2 after mRNA-1273 vaccination.Sci Rep. 2025;15:24731. [DOI] [PubMed] [PMC]
Valeri F, Endres K. How biological sex of the host shapes its gut microbiota.Front Neuroendocrinol. 2021;61:100912. [DOI] [PubMed]
Kim YS, Unno T, Kim BY, Park MS. Sex Differences in Gut Microbiota.World J Mens Health. 2020;38:48–60. [DOI] [PubMed] [PMC]
Jovanovic N, Zach V, Crocini C, Bahr LS, Forslund-Startceva SK, Franz K. A gender perspective on diet, microbiome, and sex hormone interplay in cardiovascular disease.Acta Physiol. 2024;240:e14228. [DOI] [PubMed]
Wei Y, Huo S, Liang R, Cui Y, Wang L, Zhao Y, et al. Gender‐Based Differences in Gut Microbiota Composition in Response to Anxiety and Stress in Shooting and Archery Athletes.Brain Behav. 2025;15:e70933. [DOI] [PubMed] [PMC]
Garcia I, Kilic F, Bryan CA, Castro-Vildosola J, Jonnalagadda SA, Kasturi A, et al. Social stress changes gut microbiome composition in male, female, and aggressor mice.Brain Behav Immun Health. 2025;50:101138. [DOI] [PubMed] [PMC]
Org E, Mehrabian M, Parks BW, Shipkova P, Liu X, Drake TA, et al. Sex differences and hormonal effects on gut microbiota composition in mice.Gut Microbes. 2016;7:313–22. [DOI] [PubMed] [PMC]
Yoon K, Kim N. Roles of Sex Hormones and Gender in the Gut Microbiota.J Neurogastroenterol Motil. 2021;27:314–25. [DOI] [PubMed] [PMC]
Santos-Marcos JA, Rangel-Zuñiga OA, Jimenez-Lucena R, Quintana-Navarro GM, Garcia-Carpintero S, Malagon MM, et al. Influence of gender and menopausal status on gut microbiota.Maturitas. 2018;116:43–53. [DOI] [PubMed]
Zeng J, He Z, Wang G, Ma Y, Zhang F. Interaction Between Microbiota and Immunity: Molecular Mechanisms, Biological Functions, Diseases, and New Therapeutic Opportunities.MedComm. 2025;6:e70265. [DOI] [PubMed] [PMC]
Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review.J Infect Dis. 2022;226:1593–607. [DOI] [PubMed] [PMC]
Klein J, Wood J, Jaycox JR, Dhodapkar RM, Lu P, Gehlhausen JR, et al. Distinguishing features of long COVID identified through immune profiling.Nature. 2023;623:139–48. [DOI] [PubMed] [PMC]
Ortona E, Malorni W. Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy.Eur Respir J. 2022;59:2102245. [DOI] [PubMed] [PMC]
Dou DR, Zhao Y, Belk JA, Zhao Y, Casey KM, Chen DC, et al. Xist ribonucleoproteins promote female sex-biased autoimmunity.Cell. 2024;187:733–49.e16. [DOI] [PubMed] [PMC]
Hamlin RE, Pienkos SM, Chan L, Stabile MA, Pinedo K, Rao M, et al. Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution.Sci Transl Med. 2024;16:eadr1032. [DOI] [PubMed] [PMC]
Shah DP, Thaweethai T, Karlson EW, Bonilla H, Horne BD, Mullington JM, et al.; RECOVER Consortium. The Importance of Playing the Long Game With Long COVID and Long-Term Hospital Recovery.JAMA Netw Open. 2025;8:e2512495. [DOI] [PubMed] [PMC]
Horwitz LI, Thaweethai T, Brosnahan SB, Cicek MS, Fitzgerald ML, Goldman JD, et al. Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design.PLOS ONE. 2023;18:e0286297. [DOI] [PubMed] [PMC]
Tuomaala J, Saraste M, Smith E, Kuusi M, Westerberg E, Honkonen E, et al. Association between post-COVID-19 neuropsychiatric symptoms and persistent glial activation in the limbic system: a TSPO PET study.J Neurol. 2026;273:298. [DOI] [PubMed] [PMC]
Yu Z, Ekström S, Bellander T, Ljungman P, Pershagen G, Eneroth K, et al.; BAMSE COVID-19 Study Group. Ambient air pollution exposure linked to long COVID among young adults: a nested survey in a population-based cohort in Sweden.Lancet Reg Health Eur. 2023;28:100608. [DOI] [PubMed] [PMC]
Bedston S, Almaghrabi F, Patterson L, Agrawal U, Woolford L, Anand SN, et al. Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales.Lancet Reg Health Eur. 2023;37:100816. [DOI] [PubMed] [PMC]
Chan L, Pinedo K, Stabile MA, Hamlin RE, Pienkos SM, Ratnasiri K, et al. Prior vaccination prevents overactivation of innate immune responses during COVID-19 breakthrough infection.Sci Transl Med. 2025;17:eadq1086. [DOI] [PubMed] [PMC]
Giefing-Kröll C, Berger P, Lepperdinger G, Grubeck-Loebenstein B. How sex and age affect immune responses, susceptibility to infections, and response to vaccination.Aging Cell. 2015;14:309–21. [DOI] [PubMed] [PMC]
Fischinger S, Boudreau CM, Butler AL, Streeck H, Alter G. Sex differences in vaccine-induced humoral immunity.Semin Immunopathol. 20189;41:239–49. [DOI] [PubMed] [PMC]
Flanagan KL, Fink AL, Plebanski M, Klein SL. Sex and Gender Differences in the Outcomes of Vaccination over the Life Course.Annu Rev Cell Dev Biol. 2017;33:577–99. [DOI] [PubMed]
Sulis G, Kim JY, Rodrigue V, Gore G, Peebles A, Ulrich AK, et al. Sex-disaggregated effectiveness data reporting in COVID-19 vaccine research: a systematic review.Commun Med (Lond). 2023;3:69. [DOI] [PubMed] [PMC]
Peine C, Stoliaroff-Pepin A, Reinacher U, Heldt K, Sarganas G, Piechotta V, et al. Effectiveness of COVID-19 vaccines against post-COVID-19 condition/long COVID: systematic review and meta-analysis.Clin Microbiol Infect. 2025;31:1961–71. [DOI] [PubMed]
Fernandes MDCR, Vasconcelos GS, de Melo ACL, Matsui TC, Caetano LF, de Carvalho Araújo FM, et al. Influence of age, gender, previous SARS-CoV-2 infection, and pre-existing diseases in antibody response after COVID-19 vaccination: A review.Mol Immunol. 2023;156:148–55. [DOI] [PubMed] [PMC]
Bayram A, Demirbakan H, Günel Karadeniz P, Erdoğan M, Koçer I. Quantitation of antibodies against SARS‐CoV‐2 spike protein after two doses of CoronaVac in healthcare workers.J Med Virol. 2021;93:5560–67. [DOI] [PubMed] [PMC]
Fonseca MHG, de Souza TFG, de Carvalho Araújo FM, de Andrade LOM. Dynamics of antibody response to CoronaVac vaccine.J Med Virol. 2022;94:2139–48. [DOI] [PubMed] [PMC]
Li Z, Xiang T, Liang B, Deng H, Wang H, Feng X, et al. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.Front Immunol. 2021;12:802858. [DOI] [PubMed] [PMC]
Choudhary HR, Parai D, Chandra Dash G, Kshatri JS, Mishra N, Choudhary PK, et al. Persistence of Antibodies Against Spike Glycoprotein of SARS-CoV-2 in Healthcare Workers Post Double Dose of BBV-152 and AZD1222 Vaccines.Front Med (Lausanne). 2021;8:778129. [DOI] [PubMed] [PMC]
Khoury J, Najjar-Debbiny R, Hanna A, Jabbour A, Abu Ahmad Y, Saffuri A, et al. COVID-19 vaccine – Long term immune decline and breakthrough infections.Vaccine. 2021;39:6984–89. [DOI] [PubMed] [PMC]
Lustig Y, Sapir E, Regev-Yochay G, Cohen C, Fluss R, Olmer L, et al. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.Lancet Respir Med. 2021;9:999–1009. [DOI] [PubMed] [PMC]
Brisotto G, Muraro E, Montico M, Corso C, Evangelista C, Casarotto M, et al. IgG antibodies against SARS-CoV-2 decay but persist 4 months after vaccination in a cohort of healthcare workers.Clin Chim Acta. 2021;523:476–82. [DOI] [PubMed] [PMC]
Kim HJ, Yun HJ, Kim J, Kym S, Choi Q. Antibody response to second dose of the BNT162b2 mRNA vaccine in the first 12 weeks in South Korea: A prospective longitudinal study.Vaccine. 2022;40:437–43. [DOI] [PubMed] [PMC]
Fujigaki H, Yamamoto Y, Koseki T, Banno S, Ando T, Ito H, et al. Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2.Microbiol Spectr. 2022;10:e0118121. [DOI] [PubMed] [PMC]
Mishra SK, Pradhan SK, Pati S, Sahu S, Nanda RK. Waning of Anti-spike Antibodies in AZD1222 (ChAdOx1) Vaccinated Healthcare Providers: A Prospective Longitudinal Study.Cureus. 2021;13:e19879. [DOI] [PubMed] [PMC]
Hernández-Bello J, Morales-Núñez JJ, Machado-Sulbarán AC, Díaz-Pérez SA, Torres-Hernández PC, Balcázar-Félix P, et al. Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2.Vaccines (Basel). 2021;9:1047. [DOI] [PubMed] [PMC]
Bachmann M, Gültekin N, Stanga Z, Fehr JS, Ülgür II, Schlagenhauf P. Disparities in response to mRNA SARS-CoV-2 vaccines according to sex and age: A systematic review.New Microbes New Infect. 2025;63:101551. [DOI] [PubMed] [PMC]
Jay C, Adland E, Csala A, Lim N, Longet S, Ogbe A, et al. Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescents.Front Immunol. 2023;14:1248630. [DOI] [PubMed] [PMC]
Zhang R, Leung KY, Liu D, Fan Y, Lu L, Chan PC, et al. Correlation of Immunogenicity and Reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 Vaccines.mSphere. 2022;7:e00915-21. [DOI] [PubMed] [PMC]
Cheetham NJ, Kibble M, Wong A, Silverwood RJ, Knuppel A, Williams DM, et al. Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.eLife. 2023;12. [DOI] [PubMed] [PMC]
Ikezaki H, Nomura H, Shimono N. Dynamics of anti-Spike IgG antibody level after the second BNT162b2 COVID-19 vaccination in health care workers.J Infect Chemother. 2022;28:802–5. [DOI] [PubMed] [PMC]
Moore SC, Kronsteiner B, Longet S, Adele S, Deeks AS, Liu C, et al. Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens.Med. 2023;4:191–215.e9. [DOI] [PubMed] [PMC]
Kang YM, Minn D, Lim J, Lee KD, Jo DH, Choe KW, et al. Comparison of Antibody Response Elicited by ChAdOx1 and BNT162b2 COVID-19 Vaccine.J Korean Med Sci. 2021;36:e311. [DOI] [PubMed] [PMC]
Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, et al. Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.N Engl J Med. 2021;385:e84. [DOI] [PubMed] [PMC]
Nam M, Yun SG, Kim SW, Kim CG, Cha JH, Lee C, et al. Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses.Microbiol Spectr. 2022;10:e02495-21. [DOI] [PubMed] [PMC]
Anticoli S, Dorrucci M, Iessi E, Chiarotti F, Di Prinzio RR, Vinci MR, et al. Association between sex hormones and anti-S/RBD antibody responses to COVID-19 vaccines in healthcare workers.Hum Vaccines Immunother. 2023;19. [DOI] [PubMed] [PMC]
Gu Y, Shunmuganathan B, Qian X, Gupta R, Tan RSW, Kozma M, et al. Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2.Sci Rep. 2023;13:21810. [DOI] [PubMed] [PMC]
Braeye T, van Loenhout JAF, Brondeel R, Stouten V, Hubin P, Billuart M, et al. COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.Euro Surveill. 2023;28:2200768. [DOI] [PubMed] [PMC]
Lusvarghi S, Pollett SD, Neerukonda SN, Wang W, Wang R, Vassell R, et al. SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies.Sci Transl Med. 2022;14:eabn8543. [DOI] [PubMed] [PMC]
Tang J, Grubbs G, Lee Y, Huang C, Ravichandran S, Forgacs D, et al. Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex.eBioMedicine. 2021;74:103748. [DOI] [PubMed] [PMC]
Padoan A, Cosma C, Bonfante F, Della Rocca F, Barbaro F, Santarossa C, et al. Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays.Clin Chem Lab Med (CCLM). 2021;60:456–63. [DOI] [PubMed]
Bignucolo A, Scarabel L, Mezzalira S, Polesel J, Cecchin E, Toffoli G. Sex Disparities in Efficacy in COVID-19 Vaccines: A Systematic Review and Meta-Analysis.Vaccines (Basel). 2021;9:825. [DOI] [PubMed] [PMC]
Ferroni E, Mateo-Urdiales A, Bietta C, Cesaroni G, Anticoli S, Di Maggio E, et al. Sex differences in response to COVID-19 mRNA vaccines in Italian population.Epidemiol Infect. 2024;152:e139. [DOI] [PubMed] [PMC]
Zhu Z, Xu L, Chen G. Is there a difference in the efficacy of COVID-19 vaccine in males and females? - A systematic review and meta-analysis.Hum Vaccines Immunother. 2021;17:4741–6. [DOI] [PubMed] [PMC]
Fink AL, Klein SL. Sex and Gender Impact Immune Responses to Vaccines Among the Elderly.Physiology (Bethesda). 2015;30:408–16. [DOI] [PubMed] [PMC]
Green MS, Peer V, Magid A, Hagani N, Anis E, Nitzan D. Gender Differences in Adverse Events Following the Pfizer-BioNTech COVID-19 Vaccine.Vaccines (Basel). 2022;10:233. [DOI] [PubMed] [PMC]
Sim J, O’Guin E, Sugimoto C, Laumet S, Monahan K, Bernard MP, et al. Monocyte-derived IL-10 drives sex differences in pain duration.Sci Immunol. 2026;11:eadx0292. [DOI] [PubMed] [PMC]
Mackey E, Thelen KM, Bali V, Fardisi M, Trowbridge M, Jordan CL, et al. Perinatal androgens organize sex differences in mast cells and attenuate anaphylaxis severity into adulthood.Proc Natl Acad Sci U S A. 2020;117:23751–61. [DOI] [PubMed] [PMC]
Kitano T, Salmon DA, Dudley MZ, Saldanha IJ, Thompson DA, Engineer L. Age- and sex-stratified risks of myocarditis and pericarditis attributable to COVID-19 vaccination: a systematic review and meta-analysis.Epidemiol Rev. 2025;47:1–11. [DOI] [PubMed]
Patone M, Mei XW, Handunnetthi L, Dixon S, Zaccardi F, Shankar-Hari M, et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection.Nat Med. 2022;28:410–22. [DOI] [PubMed] [PMC]
Scully EP, Morgan R, Klein SL. Precision Vaccinology: Making Vaccines Work Better for Women and Men.J Infect Dis. 2025;232:756–9. [DOI] [PubMed] [PMC]
Alie MS, Abebe GF, Negesse Y, Adugna A, Girma D. Vaccine hesitancy in context of COVID-19 in East Africa: systematic review and meta-analysis.BMC Public Health. 2024;24:2796. [DOI] [PubMed] [PMC]
Lemarchand P, Pape M, Schwarz J. Understanding sex and gender disparities in COVID-19 mortality: a narrative review beyond biology.Biol Sex Differ. 2025;16:76. [DOI] [PubMed] [PMC]
Bartolomeo N, Lorusso L, Maldera N, Trerotoli P. Socioeconomic Barriers to COVID-19 Booster Vaccination in Southern Italy: A Retrospective Study to Evaluate Association with the Social and Material Vulnerability Index in Apulia.Vaccines (Basel). 2025;13:1255. [DOI] [PubMed] [PMC]
Dimeglio C. Natural and Vaccine-Induced Immunity in the Post-Pandemic Era: Convergence, Divergence, and Unfinished Challenges.Vaccines (Basel). 2025;13:1251. [DOI] [PubMed] [PMC]